Skip to main content
. 2012 Jul 12;11:44. doi: 10.1186/1475-2840-11-44

Figure 5.

Figure 5

Cumulative incidence of cardiovascular events (including death from cardiovascular causes, nonfatal stroke, nonfatal myocardial infarction, coronary-artery bypass grafting, percutaneous coronary intervention, revascularization for peripheral atherosclerotic artery disease, and amputation) during the entire Steno-2 study (7.8 years of randomized, controlled trial and 5.5 years of open-label observational follow-up (From N Engl J Med 2008; 358:580–591, with permission).